Genetic interstitial lung disease
- PMID: 22365249
- PMCID: PMC3292740
- DOI: 10.1016/j.ccm.2011.11.001
Genetic interstitial lung disease
Abstract
The interstitial lung diseases (ILDs), or diffuse parenchymal lung diseases, are a heterogeneous collection of more than 100 different pulmonary disorders that affect the tissue and spaces surrounding the alveoli. Patients affected by ILD usually present with shortness of breath or cough; for many, there is evidence of pulmonary restriction, decreased diffusion capacity, and radiographic appearance of alveolar and/or reticulonodular infiltrates. This article reviews the inherited ILDs, with a focus on the diseases that may be seen by pulmonologists caring for adult patients. The authors conclude by briefly discussing the utility of genetic testing in this population.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures
References
-
- Drachtman RA, Alter BP. Dyskeratosis congenita. Dermatol Clin. 1995 Jan;13(1):33–39. - PubMed
-
- Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000 Sep;110(4):768–779. - PubMed
-
- Lee HW, Blasco MA, Gottlieb GJ, Horner JW, 2nd, Greider CW, DePinho RA. Essential role of mouse telomerase in highly proliferative organs. Nature. 1998 Apr 9;392(6676):569–574. - PubMed
-
- Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet. 2004 May;36(5):447–449. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
